These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 16779512)
1. The elevated level of circulating matrix metalloproteinase-9 in patients with abdominal aortic aneurysms decreased to levels equal to those of healthy controls after an aortic repair. Watanabe T; Sato A; Sawai T; Uzuki M; Goto H; Yamashita H; Akamatsu D; Sato H; Shimizu T; Miyama N; Nakano Y; Satomi S Ann Vasc Surg; 2006 May; 20(3):317-21. PubMed ID: 16779512 [TBL] [Abstract][Full Text] [Related]
2. Elevated plasma levels of matrix metalloproteinase-9 in patients with abdominal aortic aneurysms: a circulating marker of degenerative aneurysm disease. Hovsepian DM; Ziporin SJ; Sakurai MK; Lee JK; Curci JA; Thompson RW J Vasc Interv Radiol; 2000; 11(10):1345-52. PubMed ID: 11099248 [TBL] [Abstract][Full Text] [Related]
3. Systemic dilation diathesis in patients with abdominal aortic aneurysms: a role for matrix metalloproteinase-9? van Laake LW; Vainas T; Dammers R; Kitslaar PJ; Hoeks AP; Schurink GW Eur J Vasc Endovasc Surg; 2005 Apr; 29(4):371-7. PubMed ID: 15749037 [TBL] [Abstract][Full Text] [Related]
5. Cysteine protease activity in the wall of abdominal aortic aneurysms. Abisi S; Burnand KG; Waltham M; Humphries J; Taylor PR; Smith A J Vasc Surg; 2007 Dec; 46(6):1260-6. PubMed ID: 18155003 [TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase 9 activity in patients before and after endovascular or surgical repair of abdominal aortic aneurysms. Taurino M; Visco V; Raffa S; Ricci B; Ruggiero M; Torrisi MR; Fiorani P Vascular; 2004; 12(5):312-7. PubMed ID: 15765912 [TBL] [Abstract][Full Text] [Related]
7. Stromelysin-1 (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase-3 are overexpressed in the wall of abdominal aortic aneurysms. Carrell TW; Burnand KG; Wells GM; Clements JM; Smith A Circulation; 2002 Jan; 105(4):477-82. PubMed ID: 11815431 [TBL] [Abstract][Full Text] [Related]
8. Enhanced expression of matrix metalloproteinase-9 in abdominal aortic aneurysms. Yamashita A; Noma T; Nakazawa A; Saito S; Fujioka K; Zempo N; Esato K World J Surg; 2001 Mar; 25(3):259-65. PubMed ID: 11343173 [TBL] [Abstract][Full Text] [Related]
10. Biomarkers for abdominal aortic aneurysms from a sex perspective. Villard C; Wågsäter D; Swedenborg J; Eriksson P; Hultgren R Gend Med; 2012 Aug; 9(4):259-266.e2. PubMed ID: 22721599 [TBL] [Abstract][Full Text] [Related]
11. Serum matrix metalloproteinase-9 is a valuable biomarker for identification of abdominal and thoracic aortic aneurysm: a case-control study. Li T; Jiang B; Li X; Sun HY; Li XT; Jing JJ; Yang J BMC Cardiovasc Disord; 2018 Oct; 18(1):202. PubMed ID: 30373522 [TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms. Davis V; Persidskaia R; Baca-Regen L; Itoh Y; Nagase H; Persidsky Y; Ghorpade A; Baxter BT Arterioscler Thromb Vasc Biol; 1998 Oct; 18(10):1625-33. PubMed ID: 9763536 [TBL] [Abstract][Full Text] [Related]
13. Influence of cardiovascular risk factors on levels of matrix metalloproteinases 2 and 9 in human abdominal aortic aneurysms. Dilmé JF; Bellmunt S; Camacho M; Solà-Villà D; Romero JM; Escudero JR; Vila L Eur J Vasc Endovasc Surg; 2014 Oct; 48(4):374-81. PubMed ID: 24980077 [TBL] [Abstract][Full Text] [Related]
14. Plasma levels of metalloproteinases-3 and -9 as markers of successful abdominal aortic aneurysm exclusion after endovascular graft treatment. Sangiorgi G; D'Averio R; Mauriello A; Bondio M; Pontillo M; Castelvecchio S; Trimarchi S; Tolva V; Nano G; Rampoldi V; Spagnoli LG; Inglese L Circulation; 2001 Sep; 104(12 Suppl 1):I288-95. PubMed ID: 11568071 [TBL] [Abstract][Full Text] [Related]
15. MMP-9: biomarker for abdominal aneurysm. Affirul CA; Azim IM; Hanafiah H; Nor Azmi K; Rozman Z Clin Ter; 2013; 164(6):e479-83. PubMed ID: 24424226 [TBL] [Abstract][Full Text] [Related]
16. Enhanced matrix-degrading proteolytic activity within the thin thrombus-covered wall of human abdominal aortic aneurysms. Wiernicki I; Stachowska E; Safranow K; Cnotliwy M; Rybicka M; Kaczmarczyk M; Gutowski P Atherosclerosis; 2010 Sep; 212(1):161-5. PubMed ID: 20537648 [TBL] [Abstract][Full Text] [Related]
17. Circulating biochemical marker levels of collagen metabolism are abnormal in patients with abdominal aortic aneurysm. Nakamura M; Tachieda R; Niinuma H; Ohira A; Endoh S; Hiramori K; Makita S Angiology; 2000 May; 51(5):385-92. PubMed ID: 10826855 [TBL] [Abstract][Full Text] [Related]
19. Transglutaminase type 2 in human abdominal aortic aneurysm is a potential factor in the stabilization of extracellular matrix. Shin S; Cho YP; Jun H; Park H; Hong HN; Kwon TW J Vasc Surg; 2013 May; 57(5):1362-70. PubMed ID: 23538006 [TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase 8 (neutrophil collagenase) in the pathogenesis of abdominal aortic aneurysm. Wilson WR; Schwalbe EC; Jones JL; Bell PR; Thompson MM Br J Surg; 2005 Jul; 92(7):828-33. PubMed ID: 15918165 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]